Register
Forgot your password?

Surgical treatment of atrial fibrillation during coronary artery bypass grafting

Authors: Dzhamaldinov I.A., Serguladze S.Yu., Berdibekov B.Sh.

Company: Bakoulev National Medical Research Center for Cardiovascular Surgery, Moscow, Russian Federation

For correspondence:  Sign in or register.

Type:  Reviews


DOI: https://doi.org/10.24022/1997-3187-2026-20-2-175-184

For citation: Dzhamaldinov I.A., Serguladze S.Yu., Berdibekov B.Sh. Surgical treatment of atrial fibrillation during coronary artery bypass grafting. Creative Cardiology. 2026; 20 (2): 175–184 (in Russ.). DOI: 10.24022/1997-3187-2026-20-21-175-184

Received / Accepted:  07.05.2026 / 25.05.2026

Keywords: atrial fibrillation ischemic heart disease coronary artery bypass grafting radiofrequency ablation



Subscribe 🔒

 

Abstract

An analysis of contemporary literature demonstrates that atrial fibrillation (AF) significantly worsens the course of ischemic heart disease and adversely affects prognosis in patients undergoing coronary artery bypass grafting (CABG), increasing the risk of thromboembolic events, heart failure, and mortality. In this context, the strategy of concomitant surgical correction of AF during CABG has gained particular importance. The most commonly employed techniques include pulmonary vein isolation and various modifications of the Maze procedure, particularly the Cox Maze IV, which allow effective targeting of the arrhythmogenic substrate within a single intervention. Clinical studies indicate that the addition of ablation to CABG significantly increases the rate of sinus rhythm maintenance, improves patients’ quality of life, and is associated with a reduced risk of stroke and improved long-term survival. The extent of ablation is determined by the form of AF, duration of arrhythmia, and structural cardiac changes: pulmonary vein isolation is often sufficient in patients with paroxysmal AF, whereas more extensive lesion sets, such as the Maze procedure, are preferred in persistent forms. Despite concerns regarding a potential increase in operative risk, accumulated evidence supports the clinical validity of this approach when appropriate patient selection is ensured. Thus, the present review is aimed at analyzing contemporary surgical strategies for the treatment of AF in patients undergoing CABG, with an assessment of their efficacy, safety, and impact on clinical outcomes.

References

  1. World Health Organization. Global health estimates: deaths by cause, age, sex, by country and by region, 2000–2016. Geneva: World Health Organization; 2018.
  2. Schnabel R.B., Yin X., Gona P. et al. 50-year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015; 386 (9989): 154–162. DOI: 10.1016/S0140-6736(14)61774-8
  3. Romanov A., Martinek M., Pürerfellner H. et al. Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study. Europace. 2018; 20 (2): 263–270. DOI: 10.1093/europace/euw344
  4. Malaisrie S.C., McCarthy P.M., Kruse J. et al. Ablation of atrial fibrillation during coronary artery bypass grafting: late outcomes in a Medicare population. J. Thorac. Cardiovasc. Surg. 2021; 161 (4): 1251–1261.e1. DOI: 10.1016/j.jtcvs.2019.10.159
  5. Kowalewski M., Jasiński M., Staromłyński J. et al. Long-term survival following surgical ablation for atrial fibrillation concomitant to isolated and combined coronary artery bypass surgery: analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK). J. Clin. Med. 2020; 9 (5): 1345. DOI: 10.3390/jcm9051345
  6. Rankin J.S., Lerner D.J., Braid-Forbes M.J. et al. Surgical ablation of atrial fibrillation concomitant to coronary artery bypass grafting provides cost-effective mortality reduction. J. Thorac. Cardiovasc. Surg. 2020; 160 (3): 675–686.e13. DOI: 10.1016/j.jtcvs.2019.07.131
  7. Schaffer J.M., Kluis A., Squiers J.J. et al. Survival after surgical ablation of atrial fibrillation during coronary artery bypass in Medicare beneficiaries. Ann. Thorac. Surg. 2025; 120 (4): 693–703. DOI: 10.1016/j.athoracsur.2025.03.044
  8. Cherniavsky A.M., Kareva Y.E., Pak I.A. et al. Experience of radiofrequency ablation of atrial fibrillation combined with coronary artery bypass grafting in patients with coronary artery disease. Annals of Arrhythmology. 2011; 8 (2): 30–35 (in Russ.).
  9. Pokushalov E., Romanov A., Corbucci G. et al. Benefit of ablation of first diagnosed paroxysmal atrial fibrillation during coronary artery bypass grafting: a pilot study. Eur. J. Cardiothorac. Surg. 2012; 41 (3): 556–560. DOI: 10.1093/ejcts/ezr101
  10. Pokushalov E., Romanov A., Cherniavsky A. et al. Ablation of paroxysmal atrial fibrillation during coronary artery bypass grafting: 12 months’ follow-up through implantable loop recorder. Eur. J. Cardiothorac. Surg. 2011; 40 (2): 405–411. DOI: 10.1016/j.ejcts.2010.11.083
  11. Ryazanov M.V., Khodzhaev F.S., Vaikin V.E. et al. Comparative evaluation of radiofrequency cardiac ablation techniques in patients with coronary artery disease and concomitant atrial fibrillation. Medical Almanac. 2017; 48 (3): 87–89 (in Russ.).
  12. Zotov A.S., Vachev S.A., Korolev S.V. et al. A novel approach to the treatment of patients with coronary artery disease and atrial fibrillation. Bulletin of the N.I. Pirogov National Medical and Surgical Center. 2021; 16 (2): 33–38 (in Russ.). DOI: 10.25881/20728255_2021_16_2_33
  13. Kuz’min D.N., Stonogin A.V., Lednev P.V., Belov Yu.V. Treatment of paroxysmal atrial fibrillation in coronary artery bypass grafting: concomitant surgical ablation or drug therapy? Russian Journal of Cardiology and Cardiovascular Surgery. 2014; 7 (3): 40–43 (in Russ.).
  14. Cox J.L., Boineau J.P., Schuessler R.B. et al. Electrophysiologic basis, surgical development, and clinical results of the maze procedure for atrial flutter and atrial fibrillation. Adv. Card. Surg. 1995; 6: 1–67.
  15. Cox J.L. The surgical treatment of atrial fibrillation. IV. Surgical technique. J. Thorac. Cardiovasc. Surg. 1991; 101 (4): 584–592.
  16. Cox J.L., Boineau J.P., Schuessler R.B. et al. Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results. J. Thorac. Cardiovasc. Surg. 1995; 110 (2): 473–484. DOI: 10.1016/S0022-5223(95)70244-X
  17. Mariani M.A., Stoker T., Scholten M.F. et al. Concomitant off-pump modified maze and coronary surgery. Ann. Thorac. Surg. 2011; 91 (6): e96–e98. DOI: 10.1016/j.athoracsur.2011.01.094
  18. Schill M.R., Musharbash F.N., Hansalia V. et al. Late results of the Cox-Maze IV procedure in patients undergoing coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 2017; 153 (5): 1087–1094. DOI: 10.1016/j.jtcvs.2016.12.034
  19. Revishvili A.Sh., Popov V.A., Aminov V.V. et al. Surgical treatment of paroxysmal atrial fibrillation concomitant to coronary artery bypass grafting: pulmonary vein isolation or maze V? Complex Issues of Cardiovascular Diseases. 2022; 11 (4): 47–61 (in Russ.). DOI: 10.17802/2306-1278-2022-11-4-47-61
  20. Revishvili A.Sh., Popov V.A., Malyshenko E.S. et al. Is Maze V procedure justified for paroxysmal form of atrial fibrillation in combination with coronary bypass grafting surgery? Grudnaya i Serdechno-Sosudistaya Khirurgiya. 2024; 66 (4): 493–507 (in Russ.). DOI: 10.24022/0236-2791-2024-66-4-493-507
  21. Budera P., Straka Z., Osmančík P. et al. Comparison of cardiac surgery with left atrial surgical ablation vs cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study. Eur. Heart J. 2012; 33 (21): 2644–2652. DOI: 10.1093/eurheartj/ehs290
  22. Lönnerholm S., Blomström P., Nilsson L. et al. Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation. 2000; 101 (22): 2607–2611. DOI: 10.1161/01.CIR.101.22.2607
  23. Panagov Z.G., Kanametov T.N., Shvartz V.A., Averina I.I., Donakanyan S.A., Aygumov R.N., Shengeliya L.D. The role of inflammation in the development of postoperative atrial fibrillation after coronary bypass surgery and/or aortic valve replacement: the results of the study. Annaly Aritmologii. 2025; 22 (1): 41–48 (in Russ.). DOI: 10.15275/annaritmol.2025.1.5
  24. Avanesyan G.A., Filatov A.G., Shalov R.Z. Atrial fibrillation in young patients. Annaly Aritmologii. 2024; 21 (2): 122–134 (in Russ.). DOI: 10.15275/annaritmol.2024.2.7
  25. Romanchuk D.V., Khotsanyan C.V., Arakelyan M.G. Risk factors of recurrent atrial fibrillation after catheter ablation. Creative Cardiology. 2023; 17 (1): 50–64 (in Russ.). DOI: 10.24022/1997-3187-2023-17-1-50-64
  26. Sigaev I.Yu., Keren M.A., Kazaryan A.V. et al. Subclavian-coronary bypass graft re-operation according to the MICS technique in a patient with angina relapse. Russian Journal of Cardiology. 2019; 8: 94–96 (in Russ.). DOI: 10.15829/1560-4071-2019-8-94-96
  27. Golukhova E.Z., Keren M.A., Zavalikhina T.V. et al. Potential of machine learning methods in operational risk stratification in patients with coronary artery disease scheduled for coronary bypass surgery. Russian Journal of Cardiology. 2023; 28 (2): 5211 (in Russ.). DOI: 10.15829/1560-4071-2023-5211

About Authors

  • Islam A. Dzhamaldinov, Cardiovascular Surgeon; ORCID
  • Sergey Yu. Serguladze, Dr. Med. Sci., Head of Department; ORCID
  • Bektur Sh. Berdibekov, Cand. Med. Sci., Senior Researcher, Cardiologist; ORCID

Chief Editor

Elena Z. Golukhova, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, Director of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by